Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 497

1.

Transient lesion in the splenium of the corpus callosum in acute uncomplicated falciparum malaria.

Laothamatas J, Sammet CL, Golay X, Van Cauteren M, Lekprasert V, Tangpukdee N, Krudsood S, Leowattana W, Wilairatana P, Swaminathan SV, DeLaPaz RL, Brown TR, Looareesuwan S, Brittenham GM.

Am J Trop Med Hyg. 2014 Jun;90(6):1117-1123. doi: 10.4269/ajtmh.13-0665. Epub 2014 Mar 10.

2.

Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in Plasmodium falciparum infected adults from Thailand.

Krudsood S, Looareesuwan S, Wilairatama P, Leowattana W, Tangpukdee N, Chalermrut K, Ramanathan S, Navaratnam V, Olliaro P, Vaillant M, Kiechel JR, Taylor WR.

Trop Med Int Health. 2011 Apr;16(4):458-65. doi: 10.1111/j.1365-3156.2010.02714.x. Epub 2011 Jan 10.

3.

Factors associated with acute renal failure in severe falciparum [corrected] malaria patients.

Vannaphan S, Walters N, Saengnedsawang T, Tangpukdee N, Kham-In P, Klubprasit M, Wilairatana P, Looareesuwan S.

Southeast Asian J Trop Med Public Health. 2010 Sep;41(5):1042-7. Erratum in: Southeast Asian J Trop Med Public Health. 2010 Nov;41(6):1512.

PMID:
21073023
4.

Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial.

Valecha N, Looareesuwan S, Martensson A, Abdulla SM, Krudsood S, Tangpukdee N, Mohanty S, Mishra SK, Tyagi PK, Sharma SK, Moehrle J, Gautam A, Roy A, Paliwal JK, Kothari M, Saha N, Dash AP, Björkman A.

Clin Infect Dis. 2010 Sep 15;51(6):684-91. doi: 10.1086/655831.

PMID:
20687837
5.

Intravenous ibuprofen (IV-ibuprofen) controls fever effectively in adults with acute uncomplicated Plasmodium falciparum malaria but prolongs parasitemia.

Krudsood S, Tangpukdee N, Wilairatana P, Pothipak N, Duangdee C, Warrell DA, Looareesuwan S.

Am J Trop Med Hyg. 2010 Jul;83(1):51-5. doi: 10.4269/ajtmh.2010.09-0621.

6.

New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.

Krudsood S, Looareesuwan S, Tangpukdee N, Wilairatana P, Phumratanaprapin W, Leowattana W, Chalermrut K, Ramanathan S, Navaratnam V, Olliaro P, Vaillant M, Kiechel JR, Taylor WR.

Antimicrob Agents Chemother. 2010 Sep;54(9):3730-7. doi: 10.1128/AAC.01187-09. Epub 2010 Jun 14. Erratum in: Antimicrob Agents Chemother. 2010 Oct;54(10):4526.

7.

Blood stage Plasmodium falciparum antigens induce immunoglobulin class switching in human enriched B cell culture.

Potup P, Kumsiri R, Kano S, Kalambaheti T, Looareesuwan S, Troye-Blomberg M, Maneerat Y.

Southeast Asian J Trop Med Public Health. 2009 Jul;40(4):651-64.

PMID:
19842398
8.

Cerebral malaria: a new way forward with magnetic resonance imaging (MRI).

Looareesuwan S, Laothamatas J, Brown TR, Brittenham GM.

Am J Trop Med Hyg. 2009 Oct;81(4):545-7. doi: 10.4269/ajtmh.2009.07-0411.

PMID:
19815861
9.

Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.

Boggild AK, Krudsood S, Patel SN, Serghides L, Tangpukdee N, Katz K, Wilairatana P, Liles WC, Looareesuwan S, Kain KC.

Clin Infect Dis. 2009 Sep 15;49(6):841-9. doi: 10.1086/605431.

PMID:
19673614
10.

Misclassification of drug failure in Plasmodium falciparum clinical trials in southeast Asia.

Juliano JJ, Ariey F, Sem R, Tangpukdee N, Krudsood S, Olson C, Looareesuwan S, Rogers WO, Wongsrichanalai C, Meshnick SR.

J Infect Dis. 2009 Aug 15;200(4):624-8. doi: 10.1086/600892.

11.

Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children.

Lovegrove FE, Tangpukdee N, Opoka RO, Lafferty EI, Rajwans N, Hawkes M, Krudsood S, Looareesuwan S, John CC, Liles WC, Kain KC.

PLoS One. 2009;4(3):e4912. doi: 10.1371/journal.pone.0004912. Epub 2009 Mar 20.

12.

Role of known molecular markers of resistance in the antimalarial potency of piperaquine and dihydroartemisinin in vitro.

Muangnoicharoen S, Johnson DJ, Looareesuwan S, Krudsood S, Ward SA.

Antimicrob Agents Chemother. 2009 Apr;53(4):1362-6. doi: 10.1128/AAC.01656-08. Epub 2009 Feb 2.

13.

Heritability of P. falciparum and P. vivax malaria in a Karen population in Thailand.

Phimpraphi W, Paul R, Witoonpanich B, Turbpaiboon C, Peerapittayamongkol C, Louicharoen C, Casademont I, Tungpradabkul S, Krudsood S, Kaewkunwal J, Sura T, Looareesuwan S, Singhasivanon P, Sakuntabhai A.

PLoS One. 2008;3(12):e3887. doi: 10.1371/journal.pone.0003887. Epub 2008 Dec 8.

14.

Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia.

Leowattana W, Krudsood S, Tangpukdee N, Brittenham G, Looareesuwan S.

Southeast Asian J Trop Med Public Health. 2008 Jul;39(4):581-8.

15.

Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria.

Ruangweerayut R, Looareesuwan S, Hutchinson D, Chauemung A, Banmairuroi V, Na-Bangchang K.

Malar J. 2008 Oct 31;7:225. doi: 10.1186/1475-2875-7-225.

16.

Differences in genetic population structures of Plasmodium falciparum isolates from patients along Thai-Myanmar border with severe or uncomplicated malaria.

Susomboon P, Iwagami M, Tangpukdee N, Krusood S, Looareesuwan S, Kano S.

Malar J. 2008 Oct 21;7:212. doi: 10.1186/1475-2875-7-212.

17.

Lack of association of the HbE variant with protection from cerebral malaria in Thailand.

Naka I, Ohashi J, Nuchnoi P, Hananantachai H, Looareesuwan S, Tokunaga K, Patarapotikul J.

Biochem Genet. 2008 Dec;46(11-12):708-11. doi: 10.1007/s10528-008-9185-3. Epub 2008 Sep 12.

PMID:
18787944
18.

Meteorological, environmental remote sensing and neural network analysis of the epidemiology of malaria transmission in Thailand.

Kiang R, Adimi F, Soika V, Nigro J, Singhasivanon P, Sirichaisinthop J, Leemingsawat S, Apiwathnasorn C, Looareesuwan S.

Geospat Health. 2006 Nov;1(1):71-84.

PMID:
18686233
19.

Dynamic changes in white blood cell counts in uncomplicated Plasmodium falciparum and P. vivax malaria.

Tangpukdee N, Yew HS, Krudsood S, Punyapradit N, Somwong W, Looareesuwan S, Kano S, Wilairatana P.

Parasitol Int. 2008 Dec;57(4):490-4. doi: 10.1016/j.parint.2008.06.005. Epub 2008 Jul 2.

PMID:
18647661
20.

Hyponatraemia and hypokalaemia in adults with uncomplicated malaria in Thailand.

Thanachartwet V, Krudsood S, Tangpukdee N, Phumratanaprapin W, Silachamroon U, Leowattana W, Wilairatana P, Brittenham GM, Looareesuwan S, Neild GH.

Trop Doct. 2008 Jul;38(3):155-7. doi: 10.1258/td.2007.070112.

21.

Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria.

Krudsood S, Tangpukdee N, Thanchatwet V, Wilairatana P, Srivilairit S, Pothipak N, Jianping S, Guoqiao L, Brittenham GM, Looareesuwan S.

Southeast Asian J Trop Med Public Health. 2007 Nov;38(6):971-8.

22.

Suppression of Plasmodium falciparum by serum collected from a case of Plasmodium vivax infection.

Nagao Y, Kimura-Sato M, Chavalitshewinkoon-Petmitr P, Thongrungkiat S, Wilairatana P, Ishida T, Tan-Ariya P, de Souza JB, Krudsood S, Looareesuwan S.

Malar J. 2008 Jun 26;7:113. doi: 10.1186/1475-2875-7-113.

23.

Quantitation of cell-derived microparticles in plasma using flow rate based calibration.

Nantakomol D, Chimma P, Day NP, Dondorp AM, Combes V, Krudsood S, Looareesuwan S, White NJ, Pattanapanyasat K, Chotivanich K.

Southeast Asian J Trop Med Public Health. 2008 Jan;39(1):146-53.

PMID:
18567455
24.

Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.

Tangpukdee N, Krudsood S, Thanachartwet V, Pengruksa C, Phophak N, Kano S, Li G, Brittenham GM, Looareesuwan S, Wilairatana P.

Southeast Asian J Trop Med Public Health. 2008 Jan;39(1):1-8.

25.

Longitudinal study of Plasmodium falciparum and Plasmodium vivax in a Karen population in Thailand.

Phimpraphi W, Paul RE, Yimsamran S, Puangsa-art S, Thanyavanich N, Maneeboonyang W, Prommongkol S, Sornklom S, Chaimungkun W, Chavez IF, Blanc H, Looareesuwan S, Sakuntabhai A, Singhasivanon P.

Malar J. 2008 Jun 2;7:99. doi: 10.1186/1475-2875-7-99.

26.

High-dose primaquine regimens against relapse of Plasmodium vivax malaria.

Krudsood S, Tangpukdee N, Wilairatana P, Phophak N, Baird JK, Brittenham GM, Looareesuwan S.

Am J Trop Med Hyg. 2008 May;78(5):736-40.

27.

Significant association between TIM1 promoter polymorphisms and protection against cerebral malaria in Thailand.

Nuchnoi P, Ohashi J, Kimura R, Hananantachai H, Naka I, Krudsood S, Looareesuwan S, Tokunaga K, Patarapotikul J.

Ann Hum Genet. 2008 May;72(Pt 3):327-36. doi: 10.1111/j.1469-1809.2007.00424.x. Epub 2008 Feb 19.

28.

Predictive score of uncomplicated falciparum malaria patients turning to severe malaria.

Tangpukdee N, Krudsood S, Thanachartwet V, Duangdee C, Paksala S, Chonsawat P, Srivilairit S, Looareesuwan S, Wilairatana P.

Korean J Parasitol. 2007 Dec;45(4):273-82.

29.

Expression of toll-like receptors on antigen-presenting cells in patients with falciparum malaria.

Loharungsikul S, Troye-Blomberg M, Amoudruz P, Pichyangkul S, Yongvanitchit K, Looareesuwan S, Mahakunkijcharoen Y, Sarntivijai S, Khusmith S.

Acta Trop. 2008 Jan;105(1):10-5. Epub 2007 Aug 9.

PMID:
17854755
30.

Differential regulation of IgG subclasses and IgE antimalarial antibody responses in complicated and uncomplicated Plasmodium falciparum malaria.

Tangteerawatana P, Montgomery SM, Perlmann H, Looareesuwan S, Troye-Blomberg M, Khusmith S.

Parasite Immunol. 2007 Sep;29(9):475-83.

31.

Differential roles of CD36, ICAM-1, and P-selectin in Plasmodium falciparum cytoadherence in vivo.

Yipp BG, Hickey MJ, Andonegui G, Murray AG, Looareesuwan S, Kubes P, Ho M.

Microcirculation. 2007 Aug;14(6):593-602.

PMID:
17710630
32.

Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins.

Gillrie MR, Krishnegowda G, Lee K, Buret AG, Robbins SM, Looareesuwan S, Gowda DC, Ho M.

Blood. 2007 Nov 1;110(9):3426-35. Epub 2007 Aug 10.

33.

Genetic analysis of the dihydrofolate reductase-thymidylate synthase gene from geographically diverse isolates of Plasmodium malariae.

Tanomsing N, Imwong M, Pukrittayakamee S, Chotivanich K, Looareesuwan S, Mayxay M, Dolecek C, Hien TT, do Rosario VE, Arez AP, Michon P, Snounou G, White NJ, Day NP.

Antimicrob Agents Chemother. 2007 Oct;51(10):3523-30. Epub 2007 Aug 6.

34.

Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.

Krudsood S, Tangpukdee N, Muangnoicharoen S, Thanachartwet V, Luplertlop N, Srivilairit S, Wilairatana P, Kano S, Ringwald P, Looareesuwan S.

Korean J Parasitol. 2007 Jun;45(2):111-4.

35.

Suppressive effects of the anti-oxidant N-acetylcysteine on the anti-malarial activity of artesunate.

Arreesrisom P, Dondorp AM, Looareesuwan S, Udomsangpetch R.

Parasitol Int. 2007 Sep;56(3):221-6. Epub 2007 May 10.

PMID:
17544319
36.

IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.

Pitabut N, Panichakorn J, Mahakunkijcharoen Y, Hirunpetcharat C, Looareesuwan S, Khusmith S.

Southeast Asian J Trop Med Public Health. 2007 Jan;38(1):1-7.

PMID:
17539238
37.

Significant association between TNF-alpha (TNF) promoter allele (-1031C, -863C, and -857C) and cerebral malaria in Thailand.

Hananantachai H, Patarapotikul J, Ohashi J, Naka I, Krudsood S, Looareesuwan S, Tokunaga K.

Tissue Antigens. 2007 Mar;69(3):277-80.

PMID:
17493155
38.

Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.

Krudsood S, Patel SN, Tangpukdee N, Thanachartwet W, Leowattana W, Pornpininworakij K, Boggild AK, Looareesuwan S, Kain KC.

Am J Trop Med Hyg. 2007 Apr;76(4):655-8.

PMID:
17426165
39.

Relative levels of IL4 and IFN-gamma in complicated malaria: association with IL4 polymorphism and peripheral parasitemia.

Tangteerawatana P, Pichyangkul S, Hayano M, Kalambaheti T, Looareesuwan S, Troye-Blomberg M, Khusmith S.

Acta Trop. 2007 Mar;101(3):258-65. Epub 2007 Feb 23.

PMID:
17379175
40.

The genotypes of GYPA and GYPB carrying the MNSs antigens are not associated with cerebral malaria.

Naka I, Ohashi J, Patarapotikul J, Hananantachai H, Wilairatana P, Looareesuwan S, Tokunaga K.

J Hum Genet. 2007;52(5):476-9. Epub 2007 Mar 20.

PMID:
17372674
41.

Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.

Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, Guthmann JP, Nosten F, Carlton J, Looareesuwan S, Nair S, Sudimack D, Day NP, Anderson TJ, White NJ.

J Infect Dis. 2007 Apr 1;195(7):927-33. Epub 2007 Feb 26.

PMID:
17330781
42.

Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.

Naoshima-Ishibashi Y, Iwagami M, Kawazu S, Looareesuwan S, Kano S.

Travel Med Infect Dis. 2007 Mar;5(2):132-4. Epub 2006 Sep 20.

PMID:
17298921
43.

Reduction of parasite levels in patients with uncomplicated malaria by treatment with HE2000.

Frincke JM, Stickney DR, Onizuka-Handa N, Garsd A, Reading C, Krudsood S, Wilairatana P, Looareesuwan S.

Am J Trop Med Hyg. 2007 Feb;76(2):232-6.

PMID:
17297029
44.

Independent evolution of pyrimethamine resistance in Plasmodium falciparum isolates in Melanesia.

Mita T, Tanabe K, Takahashi N, Tsukahara T, Eto H, Dysoley L, Ohmae H, Kita K, Krudsood S, Looareesuwan S, Kaneko A, Björkman A, Kobayakawa T.

Antimicrob Agents Chemother. 2007 Mar;51(3):1071-7. Epub 2007 Jan 8.

45.

Minor liver profile dysfunctions in Plasmodium vivax, P. malaria and P. ovale patients and normalization after treatment.

Tangpukdee N, Thanachartwet V, Krudsood S, Luplertlop N, Pornpininworakij K, Chalermrut K, Phokham S, Kano S, Looareesuwan S, Wilairatana P.

Korean J Parasitol. 2006 Dec;44(4):295-302.

46.

Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.

Simpson JA, Agbenyega T, Barnes KI, Di Perri G, Folb P, Gomes M, Krishna S, Krudsood S, Looareesuwan S, Mansor S, McIlleron H, Miller R, Molyneux M, Mwenechanya J, Navaratnam V, Nosten F, Olliaro P, Pang L, Ribeiro I, Tembo M, van Vugt M, Ward S, Weerasuriya K, Win K, White NJ.

PLoS Med. 2006 Nov;3(11):e444.

47.

Efficacy of ivermectin treatment of cutaneous gnathostomiasis evaluated by placebo-controlled trial.

Bussaratid V, Desakorn V, Krudsood S, Silachamroon U, Looareesuwan S.

Southeast Asian J Trop Med Public Health. 2006 May;37(3):433-40.

PMID:
17120960
48.

In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome.

Noedl H, Krudsood S, Leowattana W, Tangpukdee N, Thanachartwet W, Looareesuwan S, Miller RS, Fukuda M, Jongsakul K, Yingyuen K, Sriwichai S, Ohrt C, Knirsch C.

Antimicrob Agents Chemother. 2007 Feb;51(2):651-6. Epub 2006 Nov 20.

49.

Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.

Noedl H, Krudsood S, Chalermratana K, Silachamroon U, Leowattana W, Tangpukdee N, Looareesuwan S, Miller RS, Fukuda M, Jongsakul K, Sriwichai S, Rowan J, Bhattacharyya H, Ohrt C, Knirsch C.

Clin Infect Dis. 2006 Nov 15;43(10):1264-71. Epub 2006 Oct 12.

PMID:
17051490
50.

Travelers' malaria among foreigners at the Hospital for Tropical Diseases, Bangkok, Thailand - a 6-year review (2000-2005).

Piyaphanee W, Krudsood S, Silachamroon U, Pornpininworakij K, Danwiwatdecha P, Chamnachanan S, Wilairatana P, Looareesuwan S.

Korean J Parasitol. 2006 Sep;44(3):229-32.

Supplemental Content

Loading ...
Support Center